drugset
drugset / Trial / NCT05597462

Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks

NCT05597462 ↗

Phase 1 Completed 60 enrolled Journey Medical Corporation Dr. Reddy's Laboratories Limited · collab
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this trial is to evaluate the effects of 16-week treatment with DFD-29 40 mg QD dose in comparison to Placebo on the skin, intestinal and vaginal microbiota.

Timeline

Start
2022-09-30
Primary completion
2023-05-30
Completion
2023-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 40 mg Oral

Indications

rosacea